4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Protagonist Therapeutics, Inc. (PTGX) operates in the Biotechnology industry and is headquartered in Newark, United States with about 131 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, PTGX reported $46M in revenue and ($130M) in net income.
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States.
Interactive charts & full statements → Open the PTGX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $46M | $434M | $60M | $27M | — |
| Operating Income (EBIT) | ($158M) | $253M | ($94M) | ($131M) | — |
| Net Income | ($130M) | $275M | ($79M) | ($127M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $56M | $7M | $5M | $6M | $28M |
| Operating Income (EBIT) | ($4M) | ($50M) | ($46M) | ($42M) | ($19M) |
| Net Income | $4M | ($44M) | ($39M) | ($35M) | ($12M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $668M | $745M | $358M | $248M | — |
| Total Liabilities | $54M | $69M | $21M | $32M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PTGX viewer.
About TickerBase · Data methodology & sources